Search Results for: Clinical Roundup
-
Genitope Files For $68.8M IPO; La Jolla Raises $22.68M Publicly
The cancer therapeutics company said in its prospectus it plans to use net proceeds to fund clinical trials and other research and development expenses...are acting as co-managers.By Aaron Lorenzo | BioWorld Today | Friday, August 8, 2003 -
Viruses, Bacteria Differ, Yet Share Innate Immune System's Strategy To Identify Lethal Sepsis Infection
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...The disorder and its dramatic clinical consequences, are preventable...The editorial calls "strongly for a randomized, controlled clinical trial of vitamin D analogues in the management of this disease to determine precisely whether one vitamin D analogue is superior to anotherBy David N. Leff | BioWorld Today | Monday, August 4, 2003 -
The Six-Country WHO Network Hands Down Its Final Verdict: Coronavirus Is Behind SARS
The co-authors did clinical and experimental studies to assess the role of this newly discovered coronavirus in SARS...Their paper began: "We tested clinical and postmortem samples from 436 SARS patients in six countries for infection with SARS-CoV...Laboratory investigations of clinical and postmortem samples, as already presented, fulfilled the first three criteria: (1) isolation of the virus from diseased hosts, (2) cultivation in diseased host cells, and (3) proof of filterability (to excludeBy David N. Leff | BioWorld Today | Thursday, July 31, 2003 -
Pain Perception Arises In Remote Region Of Brain's Cerebral Cortex; Gene Therapy Trial Back-Burnered
One excruciatingly painful disorder," observed clinical and research neurosurgeon Luc Jasmin, at the University of California at San Francisco, "is irritable bowel syndrome...The clinical impact of our work," he noted, "is that it opens new doors to gene therapy...The report is titled "Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitroBy David N. Leff | BioWorld Today | Monday, July 28, 2003 -
Lexicon Leads Financing Spree With Public Offering Netting $49M
Though it has no clinical candidates, Lexicon has more than 20 targets in drug discovery programs...raised $10 million, funding the company expects to use to further develop its late-stage clinical product, Neurodex...and Peninsula Equity Partners, of Menlo Park.By Aaron Lorenzo | BioWorld Today | Friday, July 25, 2003 -
Nephronophthisis, Knotty Kidney Disorder, Probed in Mice, Human Families For Genetic Mechanism
An accompanying editorial commented, "The clinical utility of these indicators will depend on the ability to measure their levels in serum or plasma accurately and reliably, and on their predictive value as demonstrated in clinical studies...The co-authors concluded that "clinical studies incorporating anti-inflammatory treatment prior to percutaneous coronary intervention are awaited with great interestBy David N. Leff | BioWorld Today | Friday, July 25, 2003 -
Human Chromosome 7 Sequenced, Reveals New Data On Elfin Facies Of Childhood Congenital Syndrome
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...The paper bears the title "Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial 9 (COMET): randomized controlled trial...In the COMET clinical trial, some 3,000 patients with chronic heart failure were assigned to receive twice-daily doses of carvedilol or metoprolol for about five yearsBy David N. Leff | BioWorld Today | Monday, July 21, 2003 -
Proposed Public Offering From Vicuron Highlights Funding Rush
The company said it would apply the funding to operations, including clinical trials, vaccine manufacturing and the repayment of about $1.2 million in equipment loans and other debt...On Friday, its stock (NASDAQ:SIGA) gained 6 cents to at $1.77.By Aaron Lorenzo | BioWorld Today | Monday, July 14, 2003 -
Clot-Busting Drugs Urged By Cardiology College Denied Many Heart-Attack Patients By Doctors
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...In a clinical analysis of 60,770 U.S...And thirdly, we were able to demonstrate in real-life patients the beneficial effects of the recommended glycoprotein drugs compared with those enrolled in clinical trialsBy David N. Leff | BioWorld Today | Monday, July 14, 2003 -
Second-Harmonic Generation, Birth-Easing Relaxin Hormone Hurry Cancer Drugs To Targets
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Clinical trials of other potential uses of relaxin have found only minor side effects in humans...If these results are positive," he concluded, "the fact that relaxin is so safe means we can move relatively quickly into human clinical trialsBy David N. Leff | BioWorld Today | Tuesday, July 8, 2003 -
To Detect Infectious Pathogens In Body, Pasteur Scientists Unravel Adaptive Immunity From Innate
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...A clinical trial reported in the British Journal of Cancer on June 16, 2003, found that a therapeutic compound trademarked Aranesp from Amgen Inc., dosed once a month, corrects anemia and maintains hemoglobin levels in cancer patients not undergoing chemotherapy...The report appears in the June 2003 issue of the journal Clinical Genetics under the title "Association of the myocilin mt.1By David N. Leff | BioWorld Today | Monday, June 30, 2003 -
FDA, NCI Form Collaboration To Aid Development Of Cancer Drugs
Speeding drug approvals, by way of opening lines of communication with companies to prevent mistakes in clinical trials and the application process, appears to be at the heart of McClellan's new FDA...Well, in the first place, one of its goals is to develop biomarkers (markers of clinical benefit) for cancer drugs...For example, the NCI and FDA staffs currently are working on a clinical proteomics collaboration that could be used as a model for initiatives in areas such as diagnostic imaging andBy Kim Coghill | BioWorld Today | Tuesday, June 3, 2003 -
Newly Reported Hair-Follicle Gene,DSG4, Encodes Two-Way Protein For Reversing Baldness, Hirsutism
Science Editor Editor s note: Science Scan is a roundup of recently published biotechnology-relevant research...Christiano envisages starting clinical trials for hair removal by mid-winterBy David N. Leff | BioWorld Today | Monday, May 12, 2003 -
From Touted Vioxx Pain-Killer Drug To PD Rescue, Anti-COX-2 Blocker Salvages Dopamine Brain Neurons
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...So has Celebrex, which is virtually identical to Vioxx in chemical structure and clinical use...We're planning human clinical trials," he concluded, "to test the drug in PD patients." "Science & Technology Ventures," an activity of the university's Intellectual Property Office, told BioWorld Today, "We are discussing a possible strategy concerning the discovery, at this timeBy David N. Leff | BioWorld Today | Friday, April 11, 2003 -
Alabamian Scientists Blow Cover On HIV/AIDS Virus' Quick-Change, Vaccine Defying, Escapist Artistry
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...The consortium conducted a randomized clinical trial in more than 7,200 patients 5 to 66 years of age from 32 countries to assess the effects of budesonide (Pulmicort Turbuhaler, AstraZeneca plcBy David N. Leff | BioWorld Today | Thursday, April 3, 2003 -
New Research Shows Breast Cancers Spawn Rare Stem Cells, Which Create Metastatic Tumors
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Their report appears in the current Journal of Clinical Microbiology, released online Feb. 7, 2003, under the title: "Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patientsBy David N. Leff | BioWorld Today | Tuesday, March 4, 2003 -
Misfolded Amyloid Proteins Threaten Many Amyloidosis Diseases, Notably Liver, Heart
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Encouraged by tests on animals and in healthy human volunteers," the New York Times dated Jan. 31, 2003 reported, "the researchers are about to begin clinical trials on patients with the twoBy David N. Leff | BioWorld Today | Monday, February 10, 2003 -
Ecopia Drills Deep Into Genome- Based, High-Throughput System To Reveal Antitumor Enediynes
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Results of their double-blind, placebo-controlled clinical trial are reported in the current issue of The Lancet, dated Jan. 25, 2003...The number of patients enrolled was small, so larger clinical trials should be done to confirm our findingsBy David N. Leff | BioWorld Today | Monday, February 3, 2003 -
Is Sex Really Overrated? Yes And No, Testify Cultured Mutant Yeasts, Relying On Asexual Reproduction
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Recent advances in the use of tumor-specific immunotherapies, such as the monoclonal antibody Herceptin, have shown clinical efficacy for the treatment of metastatic mammary malignancies overexpressed by breast cancer tumorsBy David N. Leff | BioWorld Today | Wednesday, January 29, 2003 -
Texans Use Phage-Display Screen To Design Antibody Blood Test For Prostate Cancer Management
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Novel tools for biochemically staging disease would help physicians and patients evaluate and select the most appropriate clinical approach...Ten years later, in 1754, a controlled clinical trial on another British vessel, fed 12 scurvy patients a variety of foodsBy David N. Leff | BioWorld Today | Thursday, January 16, 2003
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.